Go to the Content   Thursday, 9 February 2012

Alastair Kent related content Alastair Kent topic RSS

Your search for "Alastair Kent" produced 8 items.

1. Access to treatments: which rights for patients? February 17, 2009

A European Voice Health-check debate

Access to treatments: which rights for patients?

2. Access to treatments: which rights for patients? February 17, 2009

Patients will cross national borders for medical treatment in increasing numbers, but they still face substantial political, financial and technical obstacles, according to a...

Access to treatments: which rights for patients?

3. Biotechnology patenting deal set for approval November 20, 1997

THE patenting of components of the human body such as DNA is likely to be approved by internal market ministers when they meet next week, finally bringing years of wrangling...

4. Feelings running high over patent rules July 10, 1997

SUPPORTERS and opponents of biotechnological inventions are set to clash next week as the European Parliament considers new patenting rules for the industry. The debate will...

5. In the eye of the biotechnology storm July 3, 1997

FEW issues can stir up as much feeling as biotechnological research. The actual processes involved may be highly technical and comprehensible only to those with keenly...

6. Panel's paper on cloning under attack June 5, 1997

ANIMAL rights campaigners and Green MEPs have joined forces in condemning a report compiled by a panel of scientific, legal and ethical experts on the ethical issues raised...

7. EU urged to set up ethics watchdog April 17, 1997

PRESSURE is growing for the creation of a European watchdog to investigate and assess the ethical implications of biotechnological advances in the Union. Supporters of the...

8. LETTERS October 24, 1996

From Tony Venables andJohn RichardsonSince European Voice is devoting a lot of attention to non-governmental organisations (NGOs) – and we are grateful for that – your...

Showing 1-8 of 8        



 

 

 

 

 

Disclaimer | Privacy policy | Terms & conditions